Search

Golam M. Shameem

Examiner (ID: 11001, Phone: (571)272-0706 , Office: P/1626 )

Most Active Art Unit
1621
Art Unit(s)
1621, 1622, 1626
Total Applications
3199
Issued Applications
2366
Pending Applications
304
Abandoned Applications
576

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14621821 [patent_doc_number] => 20190224278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => PRODUCING METHOD OF ANTIMICROBIAL PEPTIDE WITH ENHANCED ADHESION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/175640 [patent_app_country] => US [patent_app_date] => 2018-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5671 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175640 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/175640
PRODUCING METHOD OF ANTIMICROBIAL PEPTIDE WITH ENHANCED ADHESION AND USES THEREOF Oct 29, 2018 Abandoned
Array ( [id] => 16204873 [patent_doc_number] => 20200237863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => Combination Therapy of Fractionated Radiation and SAPC-DOPS for the Treatment of Tumors [patent_app_type] => utility [patent_app_number] => 16/756251 [patent_app_country] => US [patent_app_date] => 2018-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756251 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/756251
Combination Therapy of Fractionated Radiation and SAPC-DOPS for the Treatment of Tumors Oct 15, 2018 Abandoned
Array ( [id] => 13870773 [patent_doc_number] => 20190031727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => ORAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 16/157842 [patent_app_country] => US [patent_app_date] => 2018-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14113 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157842 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/157842
ORAL ADMINISTRATION Oct 10, 2018 Abandoned
Array ( [id] => 13826545 [patent_doc_number] => 20190016757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => ANTIMICROBIAL PEPTIDES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/145064 [patent_app_country] => US [patent_app_date] => 2018-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13118 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16145064 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/145064
Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof Sep 26, 2018 Issued
Array ( [id] => 17236669 [patent_doc_number] => 11180541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-23 [patent_title] => Recombinant collagen and elastin molecules and uses thereof [patent_app_type] => utility [patent_app_number] => 16/144914 [patent_app_country] => US [patent_app_date] => 2018-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27977 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16144914 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/144914
Recombinant collagen and elastin molecules and uses thereof Sep 26, 2018 Issued
Array ( [id] => 16924066 [patent_doc_number] => 11045522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => Glucagon-like peptide 1 receptor agonists and uses thereof [patent_app_type] => utility [patent_app_number] => 16/137662 [patent_app_country] => US [patent_app_date] => 2018-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14535 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16137662 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/137662
Glucagon-like peptide 1 receptor agonists and uses thereof Sep 20, 2018 Issued
Array ( [id] => 15647235 [patent_doc_number] => 20200086147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-19 [patent_title] => COMPOSITION OF DIGESTIVE ENZYMES AND APPETITE SUPPRESSANTS [patent_app_type] => utility [patent_app_number] => 16/130394 [patent_app_country] => US [patent_app_date] => 2018-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4126 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16130394 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/130394
COMPOSITION OF DIGESTIVE ENZYMES AND APPETITE SUPPRESSANTS Sep 12, 2018 Abandoned
Array ( [id] => 13733095 [patent_doc_number] => 20180371015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRA1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/121244 [patent_app_country] => US [patent_app_date] => 2018-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121244 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/121244
Difluoroketamide derivatives as HtrA1 inhibitors Sep 3, 2018 Issued
Array ( [id] => 13732985 [patent_doc_number] => 20180370960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => Solid Oral Formulations and Crystalline Forms of an Inhibitor of Apoptosis Protein [patent_app_type] => utility [patent_app_number] => 16/120073 [patent_app_country] => US [patent_app_date] => 2018-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9489 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16120073 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/120073
Solid Oral Formulations and Crystalline Forms of an Inhibitor of Apoptosis Protein Aug 30, 2018 Abandoned
Array ( [id] => 13603733 [patent_doc_number] => 20180353415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => Peptides and Their Use in The Treatment of Hair [patent_app_type] => utility [patent_app_number] => 16/106503 [patent_app_country] => US [patent_app_date] => 2018-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12198 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106503 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/106503
Peptides and Their Use in The Treatment of Hair Aug 20, 2018 Abandoned
Array ( [id] => 13604061 [patent_doc_number] => 20180353579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => Maspin, Maspin Derivatives, and Maspin Mimetics for Reducing ROS, Inflammation, and Skin Aging [patent_app_type] => utility [patent_app_number] => 16/104751 [patent_app_country] => US [patent_app_date] => 2018-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8623 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104751 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/104751
Maspin, Maspin Derivatives, and Maspin Mimetics for Reducing ROS, Inflammation, and Skin Aging Aug 16, 2018 Abandoned
Array ( [id] => 14273853 [patent_doc_number] => 20190134211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => CAR PEPTIDE FOR HOMING, DIAGNOSIS & TARGETED THERAPY FOR PULMONARY AND FIBROTIC DISORDERS [patent_app_type] => utility [patent_app_number] => 16/057696 [patent_app_country] => US [patent_app_date] => 2018-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16057696 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/057696
CAR PEPTIDE FOR HOMING, DIAGNOSIS & TARGETED THERAPY FOR PULMONARY AND FIBROTIC DISORDERS Aug 6, 2018 Abandoned
Array ( [id] => 14273751 [patent_doc_number] => 20190134160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => Pharmaceutical Combination for Use in Glycemic Control in Diabetes Type 2 Patients [patent_app_type] => utility [patent_app_number] => 16/038733 [patent_app_country] => US [patent_app_date] => 2018-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19128 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16038733 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/038733
Pharmaceutical Combination for Use in Glycemic Control in Diabetes Type 2 Patients Jul 17, 2018 Abandoned
Array ( [id] => 13522039 [patent_doc_number] => 20180312562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-01 [patent_title] => WATER SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/034549 [patent_app_country] => US [patent_app_date] => 2018-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -85 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034549 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/034549
WATER SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF Jul 12, 2018 Abandoned
Array ( [id] => 13551863 [patent_doc_number] => 20180327479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => Factor VIII Variants Having A Decreased Cellular Uptake [patent_app_type] => utility [patent_app_number] => 16/028603 [patent_app_country] => US [patent_app_date] => 2018-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20150 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028603 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/028603
Factor VIII variants having a decreased cellular uptake Jul 5, 2018 Issued
Array ( [id] => 15866229 [patent_doc_number] => 20200140518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => RAGE PROTEINS FOR THE TREATMENT OF FIBROSIS AND DNA DAMAGE MEDIATED DISEASES [patent_app_type] => utility [patent_app_number] => 16/625212 [patent_app_country] => US [patent_app_date] => 2018-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15957 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625212 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/625212
RAGE PROTEINS FOR THE TREATMENT OF FIBROSIS AND DNA DAMAGE MEDIATED DISEASES Jun 21, 2018 Abandoned
Array ( [id] => 18413153 [patent_doc_number] => 11667686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Erythropoietin and analogs for veterinary use [patent_app_type] => utility [patent_app_number] => 16/617380 [patent_app_country] => US [patent_app_date] => 2018-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 25185 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617380 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/617380
Erythropoietin and analogs for veterinary use Jun 4, 2018 Issued
Array ( [id] => 14018953 [patent_doc_number] => 20190071470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-07 [patent_title] => ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/000709 [patent_app_country] => US [patent_app_date] => 2018-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8696 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000709 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/000709
ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF Jun 4, 2018 Abandoned
Array ( [id] => 13440897 [patent_doc_number] => 20180271991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS [patent_app_type] => utility [patent_app_number] => 15/996612 [patent_app_country] => US [patent_app_date] => 2018-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996612 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/996612
CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS Jun 3, 2018 Abandoned
Array ( [id] => 14372461 [patent_doc_number] => 20190160143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-30 [patent_title] => ANTIBACTERIAL COMPOSITION COMPRISING MICROCIN S AND ANTIBIOTIC [patent_app_type] => utility [patent_app_number] => 15/989790 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5447 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989790 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/989790
ANTIBACTERIAL COMPOSITION COMPRISING MICROCIN S AND ANTIBIOTIC May 24, 2018 Abandoned
Menu